Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 4/20 | 0.35 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.35 |
| ▸ | DAO | P14920 | 1/20 | 0.33 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22432049 | 0.77 | CA2 (0.42) | SLC6A2SLC6A3KAT2B | |
| SCHEMBL23079347 | 0.77 | CA2 (0.38) | SLC6A2SLC6A3KAT2B | |
| SCHEMBL23317632 | 0.76 | CA2 (0.41) | SLC6A2SLC6A3KAT2B | |
| SCHEMBL12429228 | 0.75 | — | — | |
| SCHEMBL22432013 | 0.74 | — | — | |
| SCHEMBL22435683 | 0.70 | CA2 (0.39) | SLC6A2SLC6A3KAT2B | |
| SCHEMBL9030512 | 0.68 | SLC6A2 (0.33) | SLC6A2SLC6A3 | |
| SCHEMBL26999661 | 0.68 | DAO (0.59) | DAO | |
| SCHEMBL9030201 | 0.68 | DAO (0.32) | SLC6A2SLC6A3DAO | |
| Hydrochloric Acid SCHEMBL9031641 | 0.67 | SLC6A2 (0.32) | SLC6A2SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210128578-A1 | CHARGED ION CHANNEL BLOCKERS AND METHODS FOR USE | NOCION THERAPEUTICS INC (US) | 2021-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210128578-A1 | CHARGED ION CHANNEL BLOCKERS AND METHODS FOR USE | TRPV1, TRPV2, TRPV5 | SLC6A2 415/4885SLC6A3 911/4885DAO 2669/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.